Diabetes Drug Class Appears to Reduce Recurrent Gout Flares Diabetes Drug Class Appears to Reduce Recurrent Gout Flares

Previously associated with a lower incidence of gout, sodium-glucose cotransporter-2 (SGLT2) inhibitors for the first time also appear to reduce gout flare recurrence and excess mortality.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Rheumatology News Source Type: news